The Drug Supply Chain Record is the definitive compliance intelligence hub for pharmaceutical supply chain security regulations worldwide. From the US Drug Supply Chain Security Act (DSCSA) to the EU Falsified Medicines Directive (FMD), China's drug traceability system, and WHO IMPACT guidelines, this hub covers every major framework governing the serialisation, track-and-trace, and verification of pharmaceutical products.
Key Regulatory Frameworks
DSCSA (US)
Drug Supply Chain Security Act. Serialisation, track-and-trace, and EPCIS interoperability for US pharmaceutical supply chains.
Read more →EU FMD
Falsified Medicines Directive. Unique identifier, tamper-evident features, and EMVS verification for EU prescription medicines.
Read more →China Drug Traceability
NMPA drug traceability system. Serialisation and reporting requirements for all drugs sold in China.
Read more →India Track & Trace
CDSCO track-and-trace system. Barcode requirements for Schedule H and H1 drugs exported from India.
Read more →WHO IMPACT
International Medical Products Anti-Counterfeiting Taskforce. Global framework for combating counterfeit medicines.
Read more →Saudi SFDA
Saudi Food and Drug Authority track-and-trace. Serialisation requirements for drugs sold in Saudi Arabia.
Read more →Technology Solutions
Serialisation
Unique identifier assignment at item, case, and pallet level. GS1 SGTIN standards and serialisation system architecture.
Read more →Track & Trace
End-to-end supply chain visibility from manufacturer to dispenser. EPCIS event reporting and repository architecture.
Read more →2D Barcodes (GS1)
DataMatrix and QR code standards for pharmaceutical packaging. GS1 Application Identifiers and encoding requirements.
Read more →